Abstract | BACKGROUND: Twice-daily azelaic acid (AzA) is the conventional regimen for papulopustular rosacea, but once-daily AzA may be equally effective, with greater convenience and dosing flexibility. In order to test this hypothesis, an exploratory study was conducted. METHODS: The evaluable efficacy population of this 12-week double-blind, parallel-group study included 72 patients and the population that was used to report safety results included 92 patients. Baseline characteristics were comparable between the once-daily and twice-daily study groups. Evaluations were performed at baseline and at weeks 4, 8, and 12. RESULTS: No significant difference was found between the once-daily and twice-daily groups at the end of study therapy in mean investigator global assessment ( IGA) scores, treatment success, or treatment response. The mean number of inflammatory lesions, the intensity of erythema intensity, and the intensity of telangiectasia at treatment end were likewise not significantly different (P>.205 for all). More than 90% of subjects in each group rated cosmetic acceptability of this AzA gel as satisfactory or better. CONCLUSION: Based on these findings and those of prior studies, once-daily AzA 15% gel can therefore be utilized as a safe, effective, and economical dosing option for the treatment of mild-to-moderate papulopustular rosacea. Once-daily dosing of AzA 15% gel was well accepted by patients and can offer considerable dosing flexibility and convenience for the patient as well as for the dermatologist.
|
Authors | Diane M Thiboutot, Alan B Fleischer Jr, James Q Del Rosso, Klaus Graupe |
Journal | Journal of drugs in dermatology : JDD
(J Drugs Dermatol)
Vol. 7
Issue 6
Pg. 541-6
(Jun 2008)
ISSN: 1545-9616 [Print] United States |
PMID | 18561584
(Publication Type: Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Dermatologic Agents
- Dicarboxylic Acids
- Gels
- azelaic acid
|
Topics |
- Dermatologic Agents
(administration & dosage, adverse effects, therapeutic use)
- Dicarboxylic Acids
(administration & dosage, adverse effects, therapeutic use)
- Drug Administration Schedule
- Female
- Gels
- Humans
- Male
- Middle Aged
- Patient Compliance
- Patient Satisfaction
- Rosacea
(drug therapy)
- Treatment Outcome
|